The FDA warned this week that a hormone-free pill for moderate to severe menopausal hot flashes could cause: In their debate ...

CHICAGO -- Hormone therapy for menopause symptoms reduced insulin resistance in healthy postmenopausal women, a systematic ...

Respiratory disease is a leading cause of death for people with certain disabilities, such as SCI or amyotrophic lateral ...

Emergency department nurse Miles Crawford, 39, rescued a man trapped in floodwaters in New Orleans following Hurricane ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window TTHealthWatch is a weekly podcast from Texas Tech. In it, ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Adding preoperative chemoradiotherapy to perioperative ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Trastuzumab deruxtecan (Enhertu, T-DXd) therapy produced ...

The FDA approved lebrikizumab (Ebglyss) for treating atopic dermatitis in adults and children ages 12 years and up, drugmaker ...

Obeticholic acid had been awarded accelerated approval by the FDA in May 2016 as a second-line treatment for PBC patients not ...

Research presented at the annual European Respiratory Society (ERS) congress in Vienna included studies on air filtration for ...

In 2022, none of the 5 quality-of-life (QoL) goals set by the U.S. National HIV/AIDS Strategy (NHAS) were met for adults with ...

The prevalence of hormone therapy use among women over 40 was 4.6% in 2007, and declined consistently to a low of 1.8% in ...